Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Memory | 16 | 2017 | 35 | 3.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 20 | 2022 | 170 | 3.240 |
Why?
|
| Oncolytic Virotherapy | 2 | 2023 | 2 | 1.180 |
Why?
|
| Melanoma | 2 | 2023 | 52 | 1.030 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2017 | 86 | 0.980 |
Why?
|
| Oncolytic Viruses | 1 | 2023 | 1 | 0.950 |
Why?
|
| Dengue Virus | 1 | 2023 | 2 | 0.940 |
Why?
|
| Dengue | 1 | 2023 | 5 | 0.940 |
Why?
|
| Mice | 20 | 2023 | 1607 | 0.700 |
Why?
|
| Interleukin-15 | 2 | 2022 | 11 | 0.680 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2017 | 10 | 0.660 |
Why?
|
| Cell Movement | 5 | 2017 | 105 | 0.640 |
Why?
|
| Animals | 23 | 2023 | 4552 | 0.620 |
Why?
|
| Mucous Membrane | 1 | 2017 | 40 | 0.620 |
Why?
|
| Models, Immunological | 2 | 2014 | 9 | 0.580 |
Why?
|
| Adoptive Transfer | 4 | 2012 | 44 | 0.540 |
Why?
|
| Immunity, Mucosal | 1 | 2014 | 29 | 0.500 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2012 | 29 | 0.450 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 220 | 0.450 |
Why?
|
| Mammaglobin A | 1 | 2012 | 2 | 0.440 |
Why?
|
| Whole-Body Irradiation | 1 | 2012 | 18 | 0.440 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2012 | 218 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 11 | 2019 | 432 | 0.410 |
Why?
|
| Cell Differentiation | 5 | 2017 | 146 | 0.390 |
Why?
|
| Precursor Cells, T-Lymphoid | 1 | 2010 | 1 | 0.370 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 329 | 0.330 |
Why?
|
| Neoplasms | 2 | 2022 | 247 | 0.320 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 211 | 0.320 |
Why?
|
| Lymphocyte Activation | 5 | 2010 | 209 | 0.280 |
Why?
|
| Mice, Transgenic | 6 | 2012 | 248 | 0.280 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 3 | 2012 | 4 | 0.280 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 65 | 0.270 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 14 | 0.260 |
Why?
|
| MCF-7 Cells | 1 | 2023 | 17 | 0.240 |
Why?
|
| Immunotherapy | 2 | 2023 | 62 | 0.240 |
Why?
|
| Immunity | 1 | 2023 | 24 | 0.230 |
Why?
|
| Cell Death | 1 | 2023 | 61 | 0.230 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2012 | 29 | 0.230 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 96 | 0.230 |
Why?
|
| Interferon-gamma | 4 | 2012 | 109 | 0.230 |
Why?
|
| Dendritic Cells | 3 | 2012 | 56 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 178 | 0.210 |
Why?
|
| Signal Transduction | 2 | 2017 | 482 | 0.200 |
Why?
|
| T-Box Domain Proteins | 2 | 2017 | 6 | 0.180 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 11 | 0.180 |
Why?
|
| Injections, Intralesional | 1 | 2019 | 28 | 0.180 |
Why?
|
| L-Selectin | 2 | 2012 | 13 | 0.180 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2017 | 7 | 0.180 |
Why?
|
| Lung | 5 | 2019 | 154 | 0.180 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2016 | 11 | 0.170 |
Why?
|
| Cell Communication | 2 | 2009 | 29 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 3 | 0.160 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 264 | 0.160 |
Why?
|
| Sirolimus | 1 | 2017 | 15 | 0.160 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2014 | 24 | 0.150 |
Why?
|
| Oncogenes | 1 | 2016 | 13 | 0.150 |
Why?
|
| Influenza, Human | 2 | 2019 | 46 | 0.150 |
Why?
|
| Humans | 8 | 2023 | 29337 | 0.140 |
Why?
|
| Virus Diseases | 2 | 2014 | 17 | 0.140 |
Why?
|
| Vaccines, DNA | 2 | 2012 | 6 | 0.140 |
Why?
|
| Lymphocytes | 2 | 2007 | 110 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2007 | 174 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2014 | 19 | 0.130 |
Why?
|
| Vagina | 1 | 2014 | 46 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2014 | 69 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2016 | 201 | 0.110 |
Why?
|
| Lymphoid Tissue | 3 | 2007 | 18 | 0.110 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2012 | 2 | 0.110 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2012 | 5 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 31 | 0.110 |
Why?
|
| Mice, SCID | 1 | 2012 | 55 | 0.110 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2012 | 8 | 0.110 |
Why?
|
| Lymphocyte Count | 2 | 2010 | 35 | 0.110 |
Why?
|
| Flow Cytometry | 3 | 2007 | 198 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 215 | 0.100 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2011 | 17 | 0.100 |
Why?
|
| Liver | 3 | 2007 | 173 | 0.100 |
Why?
|
| Proteins | 1 | 2011 | 72 | 0.100 |
Why?
|
| Lymphopoiesis | 1 | 2010 | 2 | 0.090 |
Why?
|
| Transgenes | 1 | 2010 | 13 | 0.090 |
Why?
|
| Immunophenotyping | 2 | 2007 | 80 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2010 | 29 | 0.090 |
Why?
|
| Antigen-Presenting Cells | 2 | 2006 | 16 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2011 | 303 | 0.080 |
Why?
|
| Listeriosis | 2 | 2004 | 5 | 0.080 |
Why?
|
| Granzymes | 1 | 2007 | 7 | 0.080 |
Why?
|
| Borrelia burgdorferi | 1 | 2007 | 1 | 0.080 |
Why?
|
| Treponema pallidum | 1 | 2007 | 4 | 0.080 |
Why?
|
| Hyaluronan Receptors | 1 | 2007 | 31 | 0.080 |
Why?
|
| Female | 3 | 2014 | 16197 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2007 | 112 | 0.070 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2006 | 3 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2007 | 55 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2016 | 263 | 0.070 |
Why?
|
| Interleukin-7 | 1 | 2006 | 19 | 0.070 |
Why?
|
| Immunity, Cellular | 2 | 2019 | 65 | 0.070 |
Why?
|
| Monocytes | 1 | 2007 | 116 | 0.070 |
Why?
|
| Bromodeoxyuridine | 1 | 2005 | 6 | 0.070 |
Why?
|
| Cell Lineage | 1 | 2005 | 29 | 0.070 |
Why?
|
| Cell Separation | 1 | 2005 | 42 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 724 | 0.070 |
Why?
|
| Vesicular stomatitis Indiana virus | 3 | 2014 | 5 | 0.070 |
Why?
|
| Organ Specificity | 3 | 2014 | 47 | 0.060 |
Why?
|
| CD40 Ligand | 1 | 2004 | 8 | 0.060 |
Why?
|
| HIV Infections | 1 | 2012 | 970 | 0.060 |
Why?
|
| Clonal Anergy | 1 | 2003 | 2 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2003 | 21 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2003 | 10 | 0.060 |
Why?
|
| Deoxycytidine | 1 | 2003 | 31 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2003 | 37 | 0.060 |
Why?
|
| Models, Biological | 1 | 2005 | 343 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 364 | 0.050 |
Why?
|
| Apoptosis | 1 | 2003 | 251 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2022 | 70 | 0.050 |
Why?
|
| Squalene | 1 | 2019 | 1 | 0.050 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 4 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 26 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2019 | 29 | 0.050 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 18 | 0.050 |
Why?
|
| Seasons | 1 | 2019 | 31 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2019 | 36 | 0.050 |
Why?
|
| Vaccination | 1 | 2019 | 41 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 81 | 0.040 |
Why?
|
| Skin | 1 | 2019 | 117 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2016 | 18 | 0.040 |
Why?
|
| Acute Disease | 1 | 2016 | 226 | 0.030 |
Why?
|
| Listeria monocytogenes | 2 | 2006 | 5 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 15 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 625 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 36 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2012 | 66 | 0.030 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2011 | 2 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2011 | 8 | 0.020 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 1 | 2011 | 6 | 0.020 |
Why?
|
| Influenza A virus | 1 | 2011 | 20 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 226 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2011 | 35 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 169 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 355 | 0.020 |
Why?
|
| Vesiculovirus | 1 | 2009 | 1 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Vesicular Stomatitis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2009 | 4 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2009 | 19 | 0.020 |
Why?
|
| G1 Phase | 1 | 2009 | 14 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 20 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2009 | 78 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 48 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 159 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 441 | 0.020 |
Why?
|
| HIV-1 | 1 | 2012 | 438 | 0.020 |
Why?
|
| Arenaviridae Infections | 1 | 2007 | 2 | 0.020 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2007 | 2 | 0.020 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2007 | 1 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2007 | 6 | 0.020 |
Why?
|
| Serum | 1 | 2007 | 9 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2006 | 8 | 0.020 |
Why?
|
| Splenectomy | 1 | 2006 | 6 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2006 | 6 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 25 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2007 | 39 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2007 | 91 | 0.020 |
Why?
|
| Stem Cells | 1 | 2006 | 46 | 0.020 |
Why?
|
| Cell Line | 1 | 2007 | 298 | 0.020 |
Why?
|
| Male | 1 | 2023 | 15621 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2007 | 90 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2007 | 676 | 0.020 |
Why?
|
| Rhabdoviridae Infections | 1 | 2004 | 1 | 0.020 |
Why?
|
| Parabiosis | 1 | 2004 | 2 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2004 | 3 | 0.020 |
Why?
|
| Rotavirus Infections | 1 | 2004 | 2 | 0.020 |
Why?
|
| Respirovirus Infections | 1 | 2004 | 2 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 57 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 2003 | 4 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2003 | 7 | 0.020 |
Why?
|
| Clone Cells | 1 | 2003 | 20 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2004 | 49 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 113 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 51 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 2003 | 1 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 11 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 13 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 14 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2003 | 11 | 0.010 |
Why?
|
| Immunization | 1 | 2003 | 47 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 145 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1616 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 1689 | 0.010 |
Why?
|